Guest Editors
Paul Klenerman, PhD, University of Oxford, UK
Nicholas M. Provine, PhD, University of Oxford, UK
Ramon Arens, PhD, Leiden University Medical Center, Netherlands
Submission Status: Open | Submission Deadline: 2 October 2025
Call for papers - Vaccines
About the Collection
Genome Medicine is calling for submissions to a new Collection on vaccines and vaccinology. We welcome submissions that deal with the broader field of vaccinology under the lens of omics: from vaccine design and testing, to the analysis of vaccine responses and effects.
Vaccines have revolutionized public health by preventing the spread and the consequences of infectious diseases: today, recent technological and scientific advances have opened new frontiers for vaccine development, from mRNA technologies to anti-cancer vaccines.
Progress in novel analytical methods have also allowed for deeper investigations of the interplay between the host genome and vaccine response, and for the identification of novel targets, driving innovation in vaccine design, efficacy, and safety.
We are now inviting the submission of Research, Method, Software, Database, and Guideline manuscripts of interest, including but not limited to the following topics:
- Innovative vaccine approaches, including mRNA vaccines and reverse vaccinology
- Vaccine design, from the identification of novel vaccine targets to the characterization of novel vaccine adjuvants and platforms
- Host genetic, cellular and immune determinants of vaccine response
- Cancer vaccines
- Vaccine testing, trial, and safety
- Global health outcomes in relation to vaccine research
Image credit: ©Kateryna_Kon / stock.adobe.com
Meet the Guest Editors
Back to topPaul Klenerman, PhD, University of Oxford, United Kingdom
Dr Paul Klenerman trained in medicine at Cambridge and Oxford and specialized in infectious diseases. He has been funded mainly by the Wellcome, initially working on HIV with Andrew McMichael and Rodney Phillips, then with Rolf Zinkernagel and Hans Hengartner in Zurich on LCMV and returning to Oxford to set up studies on T cells in chronic infections such as HCV and CMV. His group have worked on vaccines, especially adenoviral vector vaccines and the types of memory induced, including memory inflation. He currently has studies looking at unconventional T cells such as MAIT cells in infectious diseases and cancer funded by Wellcome and CRUK.
Nicholas M. Provine, PhD, University of Oxford, United Kingdom
Dr Nicholas Provine is currently a Group Leader and Wellcome Career Fellow in the Pandemic Sciences Institute, University of Oxford. His research program focuses on understanding the fundamental immunology of vaccine technologies with the aim to harness this enhanced understanding for improved vaccine design. His group uses a combination of cutting-edge cellular immunology and multi-omic techniques to perform experiments in human cohorts, organoid systems, and mouse models. He earned his PhD in Virology from Harvard University and did his postdoctoral training at the University of Oxford. For both stages of his training he elucidated key cellular regulators of the cytotoxic and humoral immune responses induced by adenovirus vector vaccines.
Ramon Arens, PhD, Leiden University Medical Center, Netherlands
Dr Ramon Arens studied Medical Biology at the University of Amsterdam and carried out his PhD research at Sanquin and Amsterdam University Medical Center in the laboratory of Prof Dr René van Lier. His postdoctoral research in the group of Prof Dr Ton Schumacher at the Netherlands Cancer Institute was followed by a research scientist position at the La Jolla Institute for Immunology. His current research at the Immunology department of Leiden University Medical Center aims to improve immunotherapy by studying the molecular and cellular regulation of T cell responses in infectious disease and cancer. Researched immunotherapies include (therapeutic) vaccines, immune checkpoint modulators, and chemo-immunotherapy.
There are currently no articles in this collection.
Submission Guidelines
Back to topThis Collection welcomes submission of original Research, Method, Software, Database, and Guideline Articles. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal. Articles for this Collection should be submitted via our submission system, Snapp. During the submission process you will be asked whether you are submitting to a Collection, please select "Vaccines" from the dropdown menu.
Articles will undergo the journal’s standard peer-review process and are subject to all of the journal’s standard policies. Articles will be added to the Collection as they are published.
The Editors have no competing interests with the submissions which they handle through the peer review process. The peer review of any submissions for which the Editors have competing interests is handled by another Editorial Board Member who has no competing interests.